Breast cancer is a pervasive global health concern among women. Leveraging multimodal data from enterprise patient databases-including Picture Archiving and Communication Systems (PACS) and Electronic Health Records (EHRs)-holds promise for improving prediction. This study introduces a multimodal deep-learning model leveraging mammogram datasets to evaluate breast cancer prediction. Our approach integrates frozen large-scale pretrained vision-language models, showcasing superior performance and stability compared to traditional image-tabular models across two public breast cancer datasets. The model consistently outperforms conventional full fine-tuning methods by using frozen pretrained vision-language models alongside a lightweight trainable classifier. The observed improvements are significant. In the CBIS-DDSM dataset, the Area Under the Curve (AUC) increases from 0.867 to 0.902 during validation and from 0.803 to 0.830 for the official test set. Within the EMBED dataset, AUC improves from 0.780 to 0.805 during validation. In scenarios with limited data, using Breast Imaging-Reporting and Data System category three (BI-RADS 3) cases, AUC improves from 0.91 to 0.96 on the official CBIS-DDSM test set and from 0.79 to 0.83 on a challenging validation set. This study underscores the benefits of vision-language models in jointly training diverse image-clinical datasets from multiple healthcare institutions, effectively addressing challenges related to non-aligned tabular features. Combining training data enhances breast cancer prediction on the EMBED dataset, outperforming all other experiments. In summary, our research emphasizes the efficacy of frozen large-scale pretrained vision-language models in multimodal breast cancer prediction, offering superior performance and stability over conventional methods, reinforcing their potential for breast cancer prediction.

This paper presents a novel Lasso Logistic Regression model based on feature-based time series data to determine disease severity and when to administer drugs or escalate intervention procedures in patients with coronavirus disease 2019 (COVID-19). Advanced features were extracted from highly enriched and time series vital sign data of hospitalized COVID-19 patients, including oxygen saturation readings, and with a combination of patient demographic and comorbidity information, as inputs into the dynamic feature-based classification model. Such dynamic combinations brought deep insights to guide clinical decision-making of complex COVID-19 cases, including prognosis prediction, timing of drug administration, admission to intensive care units, and application of intervention procedures like ventilation and intubation. The COVID-19 patient classification model was developed utilizing 900 hospitalized COVID-19 patients in a leading multi-hospital system in Texas, United States. By providing mortality prediction based on time-series physiologic data, demographics, and clinical records of individual COVID-19 patients, the dynamic feature-based classification model can be used to improve efficacy of the COVID-19 patient treatment, prioritize medical resources, and reduce casualties. The uniqueness of our model is that it is based on just the first 24 hours of vital sign data such that clinical interventions can be decided early and applied effectively. Such a strategy could be extended to prioritize resource allocations and drug treatment for futurepandemic events.

Computer-aided diagnosis (CAD) systems must constantly cope with the perpetual changes in data distribution caused by different sensing technologies, imaging protocols, and patient populations. Adapting these systems to new domains often requires significant amounts of labeled data for re-training. This process is labor-intensive and time-consuming. We propose a memory-augmented capsule network for the rapid adaptation of CAD models to new domains. It consists of a capsule network that is meant to extract feature embeddings from some high-dimensional input, and a memory-augmented task network meant to exploit its stored knowledge from the target domains. Our network is able to efficiently adapt to unseen domains using only a few annotated samples. We evaluate our method using a large-scale public lung nodule dataset (LUNA), coupled with our own collected lung nodules and incidental lung nodules datasets. When trained on the LUNA dataset, our network requires only 30 additional samples from our collected lung nodule and incidental lung nodule datasets to achieve clinically relevant performance (0.925 and 0.891 area under receiving operating characteristic curves (AUROC), respectively). This result is equivalent to using two orders of magnitude less labeled training data while achieving the same performance. We further evaluate our method by introducing heavy noise, artifacts, and adversarial attacks. Under these severe conditions, our network's AUROC remains above 0.7 while the performance of state-of-the-art approaches reduce to chance level.

Simultaneous capturing of ultrasound (US) and magnetic resonance (MR) images allows fusion of information obtained from both modalities. We propose an MR-compatible US system where MR images are acquired in a known orientation with respect to the US imaging plane and concurrent real-time imaging can be achieved. Compatibility of the two imaging devices is a major issue in the physical setup. Tests were performed to quantify the radio frequency (RF) noise introduced in MR and US images, with the US system used in conjunction with MRI scanner of different field strengths (0.5 T and 3 T). Furthermore, simultaneous imaging was performed on a dual modality breast phantom in the 0.5 T open bore and 3 T close bore MRI systems to aid needle-guided breast biopsy. Fiducial based passive tracking and electromagnetic based active tracking were used in 3 T and 0.5 T, respectively, to establish the location and orientation of the US probe inside the magnet bore. Our results indicate that simultaneous US and MR imaging are feasible with properly-designed shielding, resulting in negligible broadband noise and minimal periodic RF noise in both modalities. US can be used for real time display of the needle trajectory, while MRI can be used to confirm needle placement.